EUROPEAN SOCIEfY FOR VASCULARSURGERY REPORTS AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 European Society For Vascular Surgery Reports and financial ststements for the year ended 31 December 2024 Contents Page Trustees, report Report of the Independent auditor Statements of financial activities 12 Balance sheets 14 Consolidated statement of cash flows 15 Notes to the financlal statements 16 European Society For Vascular Surgery Trustees, rÈport for the year ended 31 December 2024 The trustees. as directors of the charitable company for the purposes of company law, present their report and financial statements for the year ended 31 December 2024. This report meets the requlrements for a Directors, Report for the purpose5 ofthe Companies Act. Alms and objertlves Purposes ond oims The Society defines its misslon as being to improve vascular health for the public benefit by: Promotin8 high quality research,. Providlng educatSonal opportunities including weblnars. workshops and h3nds-on courses. Organising meetings seminar5, workshops. lectures and conference5, both on-line and In person,. Sponsoring its Journals (Europeon Journol of Vosculor ond Endovasculorsurgery IEJVESI & EJVES Vascular Forum); Issuing Clinical Practlce Guldelines on the treatment of vascular disease,. Promoting dialogue with National Societies and others involved In the treatment of vascular d15ease; and Advisin8 regulatory authorities on matters relatln8 to vascular disease. In order to further Its objects and achieve its mission, the Soclety and Its subsldlary companies undertake a varlety of activities, details of which are 8iven below.. Annual Conference The Annual Conference has been held every year slnce 1987 in different European citles lonllne In 2020). Venues are Usually selected around flve years in advance to allow for the necessary plannin8. The programme of each Annual Conference includes scientiflc sessions, workshops and symposla, abstract presentations, a trade exhlbltlon together with a Social Programme and opportunltles for informal networking. The SocSety contract5 wlth a Professional Congress Organiser {PCOl to manage the logistical aspects of the Conference. Tronslotional Vascular Science Meetlng The Soclety held Its flr5t Spring Conference In 2013. The event wa5 concelved on a smaller scale than the Annual Conference comprising a number of Sclentlflc Sesslons Includlng a keynote lecture and a serles of abstract presentations. In 2019, the declslon was taken to change the format of the event so that it became a biennial event, alternatlng with the biennial European Symposium Of Vascular Blomaterlals Symposium. The first meetin8 due to be held in thls way was scheduled for 2020, but became an online event as a result of the Covld-19 pandemic wlth subsequent meetin8s, In 2022 and 2024, bein8 in person. Educutionol progromme The society offers a programme of training courses not only at the annual conference but also at other times through the year. Surgeon5 Wlth skills in the specific area belng covered act as tutors, and, whilst the courses are offered to all members of the Society, they are primarily aimed at surgeon5 Still in tralnln8. A sulte of short on-llne courses Is also offered. During the year, the Soclety launched a two-year programme called Fellowship available at both basic and advanced levels. In each case the programme comprises seven hands-on workshops and between six and eight online workshops. It also announced a Certification scheme, which in its pilot phases will concentrate on Endovasular procedures on the lower Ilmb. ESVS Mastercl@ss Live was launched In 2019 as a two day event whlch included commentary on Ilve operations with dlrect vldeo Ilnk to the operation rooms as well as discussions and lectures. Slnce 2019 the format has changed sllghtly and, in 2024, the event took the form of four evening sessions, all virtual. Edited videos of the event are avallable in the on-llne ESVS Library, which is available to members of the Society. The ESVS Library includes a Wirtual Va5cularf' textbook, which Is belng wrltten with individual chapter5 being launched as they are completed or updated. It 0150 includes a serles of podcast5 and other resources, made avallable to members. The Society also offers a series of webinars. which featured vascular experts discussing specialist topics. These are avallable publlcly after the Ilve "broadcast" There is also a series of Podcasts available to members. European Society For Vascular Surgery Trustees. report for the year ended 31 December 2024 (contlnuedl Alms and objectives (contlnued) Journols All members of the Society have elertronlc access to the SocIe￿5 Journals, European Journal of Vascular and Endovascular Surgery IEJVESI and EJVES Vascular Forum IVF}. These journals are owned by the Society and have been managed from the start of 2024 by European Vascular Sur8ery Tradlng Llmited IEVSTLI, a subsidiary company of the Society. For an additlonal fee, members can elect to recelve a paper copy of European EJVES each month. Guidelines The Society commissions and publishes in EJVES and an App a series of Clinical Prattice Guldelines on vascular procedures. Industry partnerships The Charty actively works with a number of medlcal device and pharmaceutical companies, which make a contrlbutlon to the Society {or one of Its subsidiaries) and become "Industry Partners". The Society also welcomes sponsorship of partlcular events, although it maintalrss its scientific Independence from such sponsors. The Society thanks It5 four industry partners from 2024 (Cook Medical, Gore, Phlllps and Medtronlc) for their support. Gronts The Society currently offers Educatlonal Travel Grants, whlch aim to allow the successful applicant to travel to an institution in a dlfferent country from where they work for a short period of tlme, to look at a particular technique or research prolect. Vascunet Vascunet Is a collaboration of vascular reglstrles that was established to Improve the quality, safety and effectiveness of vascular healthcare In Europe and Australasia. The focus of Vascunet Is the development of high-quality International reglstry data in vascular Surgery, which supports analysis of vascular surgical outcomes on an Internatlonal level and feed5 Into quality improvement project5 In multidisciplinary vascular medlclne nationally and intematlonally. Europeon Reseorch Hub The European Research Hub seeks to increase partlclpatlon In hlgh quality clinical research In vascular disease throughout Europe and internationally. European Venous Reglstry A new project started In 2024 was the creation of the European Venous Registry, whlch Is an international repository of venous treatment data that informs the outcomes of venou5 interventlons, with the ultimate 8oal to provlde patlent5 With the best P0551ble treatment accordin8 to scientlflc evldence. It is intended that the registry wlll be open for ten years. Administration. subcommlttees ond volues In 2018 the Trustee5 took a declslon to re-establish the SocieW5 own adminlstrative office as had been the case until 2015 fter which an A5s¢xiation Management company was used. The office, located in Bordeaux. France. operate5 through an wholly-owned French subsidiary ISASU ESVS France). SASU ESVS France Is responsible for employin8 Staff and provldlng the offices and equipment for those staff. The Soclety Itself has one employee Ithe Accountant) who is based in the United Klngdom. In addition to the work undertaken by the Executive Committee (Trustees), Councll and office staff, a significant amount of dministrative, planning and management work is undertaken by the Societys subcommlttees, which at the end of 2024 comprised the Pro8ramme Committee, the Industrial Relatlons and Business Development Commlttee, the Journal Committee, the ESVS Academy Committee, the Guidelines Steering Committee, the ESVS Library Committee. the National Societies Commlttee, the EJVES Editorial Board. the VF Editorial Board as well as meetings of Editors of EJVES and VF. Members ofthese commlttees are surgeons who give theirtlme voluntarily to the Society. In 2023 the Charity implemented a set of values: Integrity; Transparency- Re5pett and Sustainability. The Trustees also instituted an Equality, Diversity and Inclusion task force. The Tru5tees' aim is that the ESVS is an inclusive organisation which value5 and seeks out a diverse membership pool and promotes inclusion among member5. They believe that diversity enriches perspectives, improves performance and makes everyone feel safe and valued. European Society For Vascular Surgery Trustees. report for the year ended 31 December 2024 Icontlnued} Achlevemefits and performance The Soclety's athievements and performance are based on the activities stated above. Membership At the end of 2024 the SocSety had just over 3,300 member5 ￿preSentIng an increase of IO% on 2023. Of these just under 900 were trainee5. The Trustees and offlce staff continue to work to increase the number of members, concentrating on those countries where the proportion of Vascular Surgeons electin8 to join the Society15 lower than might be expected. Annuol Conference The 38 Annual Conference took place in Krakow, Poland, In September 2024. 1,578 delegates attended the meeting. 64 countries were represented and there were 41 Industry Sponsors. The Scientific Programme comprised 7 Fast-track sessions, 24 Symposia, two sesslons specifically for TraSnees, one Honorary Lecture and 228 e-poster sessions. The ESVS Academy ran 43 workshops. Tronslotional Meeting The ESVS Translatlonal Meeting took place in 2024 In Stockholm, Sweden, as a fully onslte event. The programme featured five sessions over the course of 1% days, dedlcated to advances in translatlonal science, The meetin8 brought together 98 delegates from 25 countries and received some financial support from two Industry partners. Ma5tercl@ss The 6, ESVS Mastercl@ss took place In four sessions between January and Aprll 2024. The first two sesslons focused on Aortlc Vascular Surgery and the Second two on Perlpheral Arterlal Disease. Vascunet In 2024, the Vascunet commlttee met once as usual, this year in Bordeaux and held a session at the Annual Conference. Journols The most recently published 151 Impact Factor of the European Journal of Vascular and Endovascular Surgery IEJVESI Is 6.8. The impact factor Is a measure of the citations from a given source, as deflned by the Institute for Scientific Information. Around one quarter of the Society's membershlp chose to receive EJVES in paper form In 2024. A new publlshlng contract for EJVES slgned durln8 2023 took effecl on l January 2024. EJVES Vascular Forum, In Its flfth year of publication, Saw Its Impart factor Increase from 1.4 to 1.8. Dr Melina Vega de Ceniga completed her term of office as Edltor-ln-chief in December 2023 and was replaced by Mr Arindam Chaudhuri. Two sets of Clinical Guidelines were completed during the year on Abdominal Aortic Aneurysm IAAA) and Peripheral Arterlal Dlsease IPADI. At the end of 2024 work was underway on Six new or updated guidelines. Educational progromme The ESVS Academy organised a series of 12 onllne events, which were attended by 137 people and covered a range of subject5 under nlne pathways. In addition 170 dele8ates attended eleven hands-on courses whlch were run In Copenha8en, Warsaw, Barcelona, Trondheim, Alkmaar, Belgrade, Stockholm, Athens and Zuyderland. The number of chapters in the Soclety's Wrtual Vascularf textbook remained at 41 at the end of 2024 whllst further material in the form of videos, podcasts and Abstract5 from the Annual Conference were added to ESVS Library. In add6tlon some out4ated material from the Library was deleted. All of these resources are avallable to the Societ¢s members. European Reseorch Hub (ERHJ The main output from the ERH during the year was the foundation of the European Venous Registry IEVeRI covered in the next section. European Society For Vascular Surgery Tyustees. report for the year ended 31 December 20241continued) Achievements and performance (contlnued) European Venous Reoistry The European Venous Registry Was established during 2024 and Is an international repository of venous treatment data that infomis the outcomes of venous interventions. with the ultimate 8021 to provide patients with the best P0551ble treatment according to scientific evidence. It is intended that the registry will be open for ten years. During the year the flrst centres jolned and data started to be received. Gronts Details of the grants awarded durlng 2024 are shown in note 7 of the financial statements. Industry Partnerships The number of Industry partnerships and the income generited from them increased In 2024, much of which came in the form of sponsorship for speclfic events. The Trustees thank the Industrial Partners and sponsors for thelr support. Administrotion The ESVS office started the year wlth eight staff, wlth an addltlonal staff member joining In the mlddle of the year to provide support for the Reglstry work. This gave a total of nine staff In addition to the Group's accountant. How the Charft￿$ artlvltles delfver publlc benefit The Trustees confirm that they have consldered the 8uidance Issued by the Charlty Commission appertalnlng to PublSc Benefit. They conslder that as all of the activltles of the Charity are condutted wlth the aim of improving the knowledge of and standard of work performed by Vascular Surgeons not onlythrou8hout Europe but the whole world thereby promoting health, It exists for the public beneflt. In order to ensure that member5hlp of the Society is available to surgeons in less affluent countries, the Society offers a reduced rate membership to sur8eons in a small number of countrles. The countries included are reviewed regularly to ensure that the discount is still valid. In addltlon a reduced membership rate is charged to surgeons in tralnlng and to retired members and reduced registration fees are offered to trainees vascular surgeons for the Annual Conference. Flnanclal Revl•w The con501idated and charity Statements of Financial Activity are set out on pages 12 and 13 of the Flnanclal Statements and show the flnancial result for the year. The group's main fundin8 sources continue to be subscriptions from members, the profits 8enerated by the EJVES, income generated by Its various charitable actlvltles and funds received from industry partners. Its main items of expenditure are staff and direct Costs for events. In 2024, the Group reported a surplus of É385,000 compared with (107,000 In 2023. This increase reflected a positive result from the Annual Conference matched by tl8ht control of costs and continued support from members and industrial partners. The charity had no restricted funds at the end of the year {2023: É20,0001. Reserves pollcy At the end of the period. the Group had funds amounting to É2,117,26712023.' É1,732.2671 of whlch É2,027,019 were free reserves la5 defined by the Charity Commlssionl. During the year the Trustees reviewed the level of free reserves that the Society should hold and concluded that an appropriate level would be between É2,200.000 and É2,600,000 in order to enable it to continue It5 activities and to mitigate agalnst the potential financial consequences of the need to provide flnancial support for its Annual Conference, as well as enable It to continue to meet it5 obligations to Its staff and running Its activities. The Trustees expect to reach thi5 increased target ran8e within the next few years. Plans for the future The 39 Annual Conference of the Society 15 due to be held in September 2025 in 15tanbul, Turkey. The Trustees and Pro8ramme Commlttee are a150 planning the 2026 Conference in Bel8rade. Serbla, and the 2027 Conference in Lisbon, Portugal, where, following a decision taken in 2023, the 2029 and 2031 Conference5 will also be held. European Society For Vascular Surgery Trustees. report for the year ended 31 December 2024 (continued) Plans for the future (continued) The Mastercl@ss event will take place in a number of sesslons throu8hout the year in 2025. Courses and podcasts continue, along with the journals 2nd e-library Includlng the on-line vascular textbook. Admin15tratively. the maln focus of 2025 is the creation of a new web51te for the Society, followinB 5i8nificant leve15 of dlssatisfaction with the existing website. The Trustees have also taken the decision to discontlnue the blannual Translational Meeting, meanlng that it will not be held In 2026. There wlll be a number of changes in the composition of the Executlve Commlttee as four Trustees reach the end of their terms of office, in addition to the annual changes assoclated wlth the role of President. In September 2025, Maarit Venermo {HelslnkS, FSnlandl will be succeeded as Secretary General by Robert Hinchliffe (Bristol, UKI, after servlnE as a Trustee for five years whilst Martln Blorck (Uppsala. Swedenl,18or Koncar and Petar Zlatanovic (both Belgrade, Serbia) have all served as Trustees for three years. Reference and adrnlnlstratlve deta115 Reoistered Company Number.. 4524120 Req15tered Charlty Number., 1093753 Address of Secretariot.. ESVS, 275 Boulevard Albert 1°, 33130 Bè8les IBordeauxl. France Reglstered offlce.. 18 Saxon Way, Romsey, Hampshire, 50515PT, Unlted Klngdom Audltor5.' Azet5 Audlt Services Limited, Gateway House, Tollgate, Chandler's Ford, Eastlei8h, Hampshlre, S053 3TG, UK BNP Paribas SA, 14 Chemin de Magret, Merlgnac. 33700, Bordeaux, France www.esvs.orB 8anker5.' Website.. Trustees The followlng Offlcers served as Trustees and made up the Executive Committee of the Soclety for the whole of the period from l January 2024 to the date of thls report unless stated otherwise.. The Presldent luntll September 20241 The Presldent Ifrom September 20241 The President Elect (from September 20241 The Deputy President-Elect (from September 20241 The Treasurer The Secretary General VES Edltor In Chlef Editor in Chief EJVES V05culor Forum Chairrnan of ESVS Academy Committee EVST Representative lan Loftus Sebastian Debus {Presldent-Elect to September 20241 Armando Mansilha (Deputy Presldent-Elett to September 2024} Nabil Chakfé Ireslgned I September 20251 Vincent Jongkind Maarit Venermo Martin 8jorck Arlndam Chaudhurl IBor Koncar Petar Zlatanovic The ESVS Council exlsts as an advlsory body to the Trustees wlth certaln speclfic responsibilities as deflned In the Article5 of Assoclatlon. It met twlce durlng the year, once on-line in May 2024 and then in person durlng the Annual Conference in Krakow in September 2024. The Societls Chief Executive Officer is Anastasia Mercherz, and the Chief Operatin8 Office 15 Natalie Helene, both based in Bordeaux, France. European Society For Vascular Surgery Trustees, report for the year ended 31 December 20241continued) Structurè, Governance and Management Governing document The European Soclety for Vascular Surgery I"ESVS"} was incorporated on 2 September 2002 and registered with the Charlty Commission on 9 September 2002 as a charity whose purpose is to relieve sickness and to preserve and protect health by advanclng for the public benefit, the sclence and art and research Into vascular disease including (wlthout limitation) vascular surgery. On 30 September 2002, the actlvltle5 of an unincorporated charlty, The European Society for Vascular Surgery (registered number 10035341, were transferred to the Society, and the latter charity was dissolved. ESVS is a company limited by guarantee govemed by its Memorandum and Articles of Association dated 28 October 2002 and amended In September 2005, September 2011, October 2020 and September 2024. Since 2020, the nine members of the Executive Committee have formed the Board of Trustees land Directors for the purposes of Company Lawl whilst the Councll (which includes the Trustees) operates as an advisory body elected directly by members. The Articles of Assoclatlon authorise the Council to create Bye Laws, which were most recently updated in 2023. These cover a number of matters relatlng to the operation of the Soclety Including categorie5 of membershlp. The liablllty of the members of the company Ifull members of the Socletyl Is Ilmlted by their guarantee. In the event of the company belng wound up durlng the period of thelr membership lor wlthln the year followln81 they undertake to contrlbute such amounts as may be required, to a maximum of Él each. Subsldlories The charity has two artive sub51dlaries. European Vascular Surgery Trading Llmlted (EVSTLI manages a number of the Socletws actlvities and in turn owns SASU ESVS France, which operates the Society's administrative office. Durlng 2023 the charity had another actlve subsidiary, European Vascular Surgery Journals Limited. whlch managed its Journals. At the end of 2023 the actlvltles of this company were transferred to EVSTL. Appolntment of trustees ond offlcers The Board of Trustees is the Executive Commlttee, comprising the Presldent, Pre5ident-Elect, Deputy President-Elert, Secretary, Treasurer, Chalrman of the Academy Commlttee. Secretsry of the EVST {tralnee section of the Society) and Edltors In Chlef of the Society's two journal5. Officers (Presldent, Secretary and Treasurer) of the Charity are proposed for electlon at the Annual General Meetln8 on the nomlnation of the Councll and take office thereafter. The President serves a one-year term of office followin8 one year as Presldent Elect and one year a5 Deputy President Elert, 8lvin8 a three year period of servlce. An indivldual may only serve as Presldent once. The Secretary and the Treasurer are elected for a five-year term of office and are not normally re- elected for a further term. The Editors in Chief serve terms of three years as do the Secretary of EVST and the Chairman of the ESVS Academy who are elected by member5 of the relevant committees. Succe550rs to the Secretary and Treasurer are elected at the Annual General Meeting one year in advance of when they assume duties and serve informally as Secretary- elect and Treasurer-elect in the year before they take office. Trustee induction and trainlng When new Trustees are appolnted, they recelve information from the Secretary advising them of thelr responslbllitie5 including informatlon supplied by the Charity Commlssion of England and Wales. They also receive the minutes of the previous meetings of the Executive Committee. New Councll Members receive information about their role as Countillors and mlnutes of the previous meeting of the Council. Orgonisatlon The Trustees meet In person at least six times each year. Three of these meetings are on-line whilst the other three are in per50n. Ad hoc on-line meetings are called if there is urgent business to be transacted between planned meetings. The ESVS council meets in person at the Annual Conference and on one other occasion online. The President chairs meetlngs of the Council, the Executive Committee and General Meetlngs. The organisation of the annual conference is undertaken by the Pr￿rarnrne Committee, which works in conjunction wlth the Executive Committee and a Professional Congress Organiser IPCOI. The Trustees thank the large number of Sur8eons lestlmated to be around 2001 who voluntarily give of their tlme and expertise to enable the Society to further its charitable oblects. European Society For Vascular Surgery Trustees, report for the year ended 31 December 2024 (Continued) Structure. Governante and Mana£ement (contlnued) Rlsk monogement policy The Trustees continue to monitor the major risk5 to which the Society might be exposed and take appropriate action as necessary to manage those ri5k5. The Charlty's Staff consider regularly the management of risk and using Key Performance Indicators report on a re8ular basis to the Trustees. Steps continue to be taken to reduce over-reliance on key individuals with wider sharing of Snformation. Related parties The Trustees have identified the Society's two wholly owned subsidiary companies, European Vascular Suryery Journals Limited and European Vascular Surgery Trading Limited, and the wholly owned subsldiary of the latter, SASU ESVS France, as being related parties. Members of the Executive Commlttee (listed above) are also related parties. In addition, some of the Trustees hold office withln their national Vascular Societies meanlng that these entities are also related parties. Details of transactions with related partie5 are provided in note 17 of the Financial Statements. Poy policyfor senior stoff With the exceptlon of the Secretary General all Trustees 8lve freely of thelr tlme to undertake their role as Trustees of the Soclety and none received remuneration In the year. Details of the Honorariurn pald to the Secretary General, honoraria paid to other Trustees for speclfic roles that they undertake for the Society and its subsidiarles and expenses paid to Trustees are given in note 8 of the flnanclal statements. The staff employed by SASU E5VS France and the Society are paid salaries commensurate wlth local rnarket conditions and the experlence of those employed. A number of other Indlvlduals are paid modest honor3rla for undertaklng specific ta5k5 for the Society and Its subsldlaries, but these In no way reflect the time commltment or the knowledge required of those Involved but are rather intended to make good some of thelr possible lost earnings in undertaking what is effectively voluntary work for the Soclety. Statement of Trustees, responslbllltles The Trustees (who are also dlrectors of the European Soclety for Vascular Sur8ery for the purposes of company lawl are responslble for preparing the Trustees, Annual Report and the financial statements In accordance with appllcable law and United Kin8dom Accountlng Standards (United Kin8dom Generally Accepted Accountin8 Practice). Company law requires the Trustees to prepare financlal statements for each financial year, whlch give a true and falr vlew of the state of affairs of the charitable company and of the Incoming resources and appllcatlon of resources, In¢ludlng the income and expendlture, of the charitable company for that perlod. In preparlnB these financlal statements, the Trustees are required to: select suitable accounting policies and then apply them conslstently; observe the methods and principles in the Charltles SORP IFRS 102}; make judgements and estimates that are reasonable and prudent; state whether applicable UK Accounting Standards have been followed, subject to any materlal departures disclosed and explalned In the flnancial statements; prepare the financial statements on the goln8 concern bas15 unless it is inapproprlate to presume that the charitable company will contlnue In operation. The Trustees are responsible for keeplng adequate accounting records that disclose with reasonable accuracy at any time the flnanclal posltlon of the charitable company and enable them to ensure that the financial 5tatement5 comply wlth the Companies Act 2006. They are also responslble for safeguarding the assets of the charltable company and hence for taking reasonable Steps for the prevention and detection of fraud and other irregularitie5. European Society For Vascular Surgery Trustees, report for the year ended 31 December 2024 (contlnued) Auditors The Trustees have taken all of the steps that they ought to have taken to make themselves aware of 3ny inforniation needed by the cornpanrfs audltor5 for the purposes of their audit and to establish that the auditors are aware of that information. The trustees are not aware of any relevant audlt informatlon of which the auditors are unaware. A resolutlon proposlng the reappolntment of Azets Audlt Servlces will be put to the forthcoming Annual General Meetin8. In preparlng thSs report the Trustees have taken advantage of the exemptions applicable to small companies. Thi5 report was approved by the Trustees on 12 September 2025 and Is slgned on their behalf by Professor Maarlt Venermo Secretary and Trustee European Society For Vaxular Surgery Independent Auditorfs Report to the members of the European So¢lety for Vascular Surgery for the year ended 31 December 2024 Oplnion We have audlted the financial statements of European Society for Vascular Surgery {the 'parent charitable cornpan￿) and its subsidiarie5 Ithe 'group'l for the year ended 31 December 2024 whlch comprise the Consolidated Statement of Flnancial Activity, Charity Statement of Financial Activity, Balance Sheets. Consolidated Statement of Cash Flows and notes to the financial statements, includlng si8nificant accounting policies. The financial reporting framework that has been applled in their preparation is applicable law and Unlted Kin8dom Accounting Standards, Including Financial ReportinB Standard 102 The Financial Reporting Stondord applicoble In the UK ond Republic of Irelond (United Klngdom Generally Accepted Accounting Practice). In our opinion the financial statements: glve a true and fair view of the state of the group's and parent charitable company's affalrs as at 31 December 2024, and of the group's incoming resources and applltatlon of resources, including its Income and expendlture, for the year then ended,, have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice,. and have been prepared in accordance with the requlrements of the Companies Act 2006 and the Charities Act 2011. Basls for oplnlon We conducted our audit in accordance wlth International Standards on Audltlng IUK) IISAS IUKII and applicable law. Our responsibilities under those standards are further descrlbed In the Audltor's responslbllltles for the audlt of the flnanclal statement5 section of our report. We are Independent of the group and parent charitable company In accordance with the ethical requlrements that are relevant to our audlt of the financial statements in the UK includlng the FRC's Ethical Standard, Ind we have fulfllled our other ethical responsibilities In accordance with these requlrements. We believe that the audlt evldence we have obtained Is sufflclent and appropriate to provide a basls for our opinlon. Concluslon$ relatlng to Kolnz concern In auditing the financial statements, we have concluded that the trustees, use of the going concern basis of accountlng In the preparation of the f inancial statements is appropriate. Based on the work we have performed, we have no identified any material uncertainties relatlng to events or ¢ondltlon5 that, individually or collectively, may case significant doubt on the group's or parent charitable companvs ability to tontinue as a goln8 concern for a period of at least twelve months from the flnancial statements are authorlsed for issue. Our responsibilities and the responsibilities of the trustees wlth respect to 80in8 concern are descrlbed in the relevant settlons of the report. Other Informatlon The other information comprlses the information included in the Trustee5' Report, other than the financial statements and our audltor's report thereon. The trustees are respon51ble for the other information contained within the Trustees, Report. Our opinion on the financial statement5 does not cover the other Informatlon and, except to the extent otherwise expllcltly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility Is to read the other infomiation and, in dolng so, conslder whèther the other Information is rnaterlally inconsistent wlth the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially mlsstated. If we Identify such material Inconslstencles or apparent material mi55tatements, we are required to determlne whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other informatlon, we are requlred to report that fact. We have nothing to report in this regard. Oplnlons on other m•tter5 prescrlbed by the Companies Art 2006 In our opinion. based on the work undertaken in the course of the audit: the Informatlon glven in the trustees, report Ilncorporatin8 the directors. report) for the financial year for which the financial statements are prepared is consistent wlth the financial statements; and the directors, Report has been prepèred in accordance wlth applicable legal requirements. European Society For Vascular Surgery Independent Auditor's Report to the members of the European So¢lety lor Vascular Surgery for the year ended 31 December 2024 (contlnued) Matters on which we are requlred to report by exception In the light of our knowledge and understanding of the group and parent charltable company and Its environment obtained in the course of the audit, we have not identified material misstatements in the Directors, Report. We have nothing to report in respect of the followln8 matters in relation to whlch the Companie5 Act 2006 and the Charities Act 2011 requires us to report to you if. in our opinion: adequate and sufficient accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or the parent charltable company's financial statements are not in agreement wlth the accounting record5 and returns; or certain dlsclosures of directors, remuneration speclfied by law are not made: or we have not received all the informatlon and explanations we require for our audit. or the trustees were not entitled to prepare the financial statements in accordance with the small companies, regime and take advantage of the small companies, exemptions In preparing the dlrectors, report and from the requirement to prepare a strategic report. Responslbllltles of trustees As explained more fully In the trustees, responsibllltles statement set out on page 7, the trustees (who are also the directors of the charltable company for the purposes of company lawl are responsible for the preparation of the flnancial statements and for belng satlsfled that they glve a true and falr vlew, and for such Internal control as the trustees determlne Is necessary to enable the preparation of financial statements that are free from materlal mlsstatement, whether due to fraud or error. In preparlng the financial statements, the trustees are responsible for assessing the group's and parent charltable companvs ablllty to continue a5 a golng concern. dlsclosin& as applicable, matters related to going concern and using the going concern basls of accountlng unless the trustees elther intend to liquldate the group or the parent charitable companv or to cease operations. or have no realistic alternatlve but to do so. Audltorfs responslbllltles for the audlt of the flnanclal statements We have been appointed auditor under the Companies Act 2006 and section 151 of the Charlties Act 2011 and report in accordance wlth those Acts. Our objectives are to obtaln reasonable assurance about whether the flnancial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor'5 report that includes our opinion. Reasonable assurance is a high level of assurance, but 15 not a 8uarantee that an audit conducted in accordance with ISAS IUKI will always detect a material mi5Statement when it exists. Misstatements can arise from fraud or error and are considered materlal If, Individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, Including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responslbllltles, outlined above, to detect material misstatements in respect of irregularltSes, includin8 fraud. The specific procedures for thls engagement and the extent to whlch these are capable of detectlng Irregularities, including fraud Is detailed below: Enquiry of management and those charged with governance around actual and potentlal litigation and claims as well as actual, suspected and alleged fraud,. Reviewing minutes of meetlngs ofthose charged with governance; Assesslng the extent of compliance with the laws and regulations consldered to have a direct material effect on the financial statements or the operations of the 2roup through enqulry and inspection; Reviewing financlal ststement disclosures and testing to supporting documentatlon to a55ess compliance with applicable laws and regulatlons; and Performing audit work over the rlsk of management bias and override of controls, including testing of journal entries and other adjustments for approprlateness, evaluating the business rationale of significant transaction5 outside the normal course of business and reviewing accountlng estimates for indicators of potential bia5. io European Soclety For Vascular Surgery Independent Audltorfs Report to the members of the European Sodety for Vas¢ular Suryery for the year ended 31 Dqcember 20241conllnued} Audltorfs re5ponslbllltles for the auth of the fln•nd•l statements (contlnued) Because of the Inherent Ilmltatlons of an audlt, there is a rlsk that we wlll not detert all Irregularities, Includln8 those leadlng to a materlal mlsstatement in the financial statements or non